Not Yet RecruitingNCT07664631
Effects of Stimulant Medications in PTSD
Medication studyAges 18–65United States
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- ChicagoSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: September 15, 2026
- Recruitment status
- Not Yet Recruiting
- Enrollment listed in the registry
- 40
- Sponsor
- University of Chicago
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07664631
- Official title
Show the full official title
Effects of Stimulant Medications in PTSD
Recruitment & locations
Not yet recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Chicago
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Chicago, a university.
Does this study involve medication?
Yes. The study involves medication, including Placebo and Adderall.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as not yet recruiting.
